v3.26.3
COMMITMENTS AND CONTINGENCIES (Details Narrative)
₪ in Thousands, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 28, 2026
USD ($)
Apr. 10, 2026
USD ($)
Jul. 01, 2024
USD ($)
Oct. 06, 2022
USD ($)
Oct. 03, 2022
Jun. 30, 2012
Mar. 31, 2025
USD ($)
Sep. 30, 2026
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2025
ILS (₪)
Sep. 30, 2025
USD ($)
Jun. 10, 2021
USD ($)
Loss Contingencies [Line Items]                        
Net sales royalty percenatge               3.00%        
Gross proceeds from cash fee percentage         7.00%              
Gross proceeds from management fee percentage         1.00%              
Proceeds from legal settlements             $ 316          
Chief Executive Officer and Executives and Certain Employees [Member]                        
Loss Contingencies [Line Items]                        
Accrued bonuses               $ 874        
Device [Member]                        
Loss Contingencies [Line Items]                        
Royalties percentage       3.00%                
Integrated Product [Member]                        
Loss Contingencies [Line Items]                        
Royalties percentage       1.50%                
At-the-Market Offering Agreement [Member] | Common Stock [Member]                        
Loss Contingencies [Line Items]                        
Aggregate offering   $ 39,231 $ 4,820                  
Percentage of placement fee     3.00%                  
Maximum [Member]                        
Loss Contingencies [Line Items]                        
Purchase of assets $ 5,000                      
Israeli Innovation Authority [Member]                        
Loss Contingencies [Line Items]                        
Grants receivable               $ 587     $ 587  
Additional grant from the IIA                 $ 673 ₪ 2,153    
Israeli Innovation Authority [Member] | Minimum [Member]                        
Loss Contingencies [Line Items]                        
Net sales royalty percenatge               3.00%        
Israeli Innovation Authority [Member] | Maximum [Member]                        
Loss Contingencies [Line Items]                        
Net sales royalty percenatge               5.00%        
Israeli Innovation Authority [Member] | CardioSert Ltd [Member]                        
Loss Contingencies [Line Items]                        
Repayment of government grants       $ 925                
Ministry of Economy [Member]                        
Loss Contingencies [Line Items]                        
Grants receivable               $ 50        
Technion Research and Development Foundation Limited [Member]                        
Loss Contingencies [Line Items]                        
Net sales royalty percenatge           3.00%            
H.C. Wainwright & Co. LLC [Member]                        
Loss Contingencies [Line Items]                        
Warrants description         The Company has also agreed to issue to Wainwright or its designees preferred investment options upon the closing of such offerings, equal to 5.0% of the aggregate number of such shares of common stock in such offerings, including upon exercise for cash of any warrants issued to investors in such offering.              
H.C. Wainwright & Co. LLC [Member] | At-the-Market Offering Agreement [Member]                        
Loss Contingencies [Line Items]                        
Offering costs                       $ 10,000
Purchase of assets       $ 8,000                
2013 Through September 30, 2026 [Member] | Israeli Innovation Authority [Member]                        
Loss Contingencies [Line Items]                        
Revenue from contract with customer, including assessed tax               $ 2,537